L-shell x-ray fluorescence computed tomography (XFCT) imaging of Cisplatin

Physics in Medicine and Biology

Volumn 59, Issue 1, 2014, Pages 219-232

  Bazalova, Magdalena ^a   Ahmad, Moiz ^a   Pratx, Guillem ^a   Xing, Lei ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURATE MEASUREMENT; ATTENUATION CORRECTION; CONCENTRATION DISTRIBUTIONS; FILTERED BACK-PROJECTION; MAXIMUM-LIKELIHOOD EXPECTATION MAXIMIZATIONS; PHOTON-COUNTING DETECTORS; TRANSMISSION DETECTORS; X-RAY FLUORESCENCE COMPUTED TOMOGRAPHY;

COMPUTERIZED TOMOGRAPHY; IMAGE RECONSTRUCTION; MONTE CARLO METHODS; PHOTONS; PLATINUM; PLATINUM COMPOUNDS; X RAYS;

SHELLS (STRUCTURES);

CISPLATIN;

ARTICLE; IMAGE PROCESSING; IMAGE QUALITY; METHODOLOGY; OPTICAL TOMOGRAPHY; SIGNAL NOISE RATIO; X RAY;

CISPLATIN; IMAGE PROCESSING, COMPUTER-ASSISTED; PHANTOMS, IMAGING; SIGNAL-TO-NOISE RATIO; TOMOGRAPHY, OPTICAL; X-RAYS;

EID: 84890660682     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/59/1/219     Document Type: Article

References (27)

1. Areberg J, Bjorkman S, Einarsson L, Frankenberg B, Lundqvist H, Mattsson S, Norrgren K, Scheike O and Wallin R 1999 Gamma camera imaging of platinum in tumours and tissues of patients after administration of Pt-191-cisplatin Acta Oncol. 38 221-8 (Pubitemid 29179778)
2. Bazalova M, Kuang Y, Pratx G and Xing L 2012 Investigation of x-ray fluorescence computed tomography (XFCT) and K-edge imaging IEEE Trans. Med. Imaging 31 1620-7
3. Berger M J, Hubbell J H, Seltzer S M, Chang J, Coursey J S, Sukumar R and Zucker D 2005 XCOM: Photon Cross Section Database NBSIR 87-3597, web version 1.3 (http://physics.nist.gov/PhysRefData/com/Text/XCOM.html)
4. Boulikas T and Vougiouka M 2003 Cisplatin and platinum drugs at the molecular level (review) Oncol. Rep. 10 1663-82
5. Cheong S-K, Jones B L, Siddiqi A K, Liu F, Manohar N and Cho S H 2010 X-ray fluorescence computed tomography (XFCT) imaging of gold nanoparticle-loaded objects using 110 kVp x-rays Phys. Med. Biol. 55 647-62
6. Cong W, Shen H, Cao G, Liu H and Wang G 2013 X-ray fluorescence tomographic system design and image reconstruction J. X-Ray Sci. Technol. 21 1-8
7. Fu G, Meng L-J, Eng P, Newville M, Vargas P and La Riviere P 2013 Experimental demonstration of novel imaging geometries for x-ray fluorescence computed tomography Med. Phys. 40 061903
8. Ginos J Z, Cooper A J L, Dhawan V, Lai J C K, Strother S C, Alcock N and Rottenberg D A 1987 N-13 Cisplatin PET to assess pharmacokinetics of intraarterial versus intravenous chemotherapy for malignant brain-tumors J. Nucl. Med. 28 1844-52 (Pubitemid 18017095)
9. Jones B L and Cho S H 2011 The feasibility of polychromatic cone-beam x-ray fluorescence computed tomography (XFCT) imaging of gold nanoparticle-loaded objects: a Monte Carlo study Phys. Med. Biol. 56 3719-30
10. Jonson R, Borjesson J, Mattsson S, Unsgaard B and Wallgren A 1991 Uptake and retention of platinum in patients undergoing Cisplatin therapy Acta Oncol. 30 315-9
11. Kawrakow I and Rogers D W O 2006 The EGSnrc code system: Monte Carlo simulation of electron and photon transport (Ottawa: NRCC) PIRS-701
12. Krause M O 1979 Atomic radiative and radiationless yields for K-shells and L-shells J. Phys. Chem. Ref. Data 8 307-27
13. Kuang Y, Pratx G, Bazalova M, Meng B, Qian J and Xing L 2013a First demonstration of multiplexed x-ray fluorescence computed tomography (XFCT) imaging IEEE Trans. Med. Imaging 32 262-7
14. Kuang Y, Pratx G, Bazalova M, Qian J, Meng B and Xing L 2013b Development of XFCT imaging strategy for monitoring the spatial distribution of platinum-based chemodrugs: instrumentation and phantom validation Med. Phys. 40 030701
15. Le Chevalier T et al and (Int Adjuvant Lung Canc Trial C) 2004 Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N. Engl. J. Med. 350 351-60 (Pubitemid 38101630)
16. Manohar N, Reynoso F J and Cho S H 2013 Experimental demonstration of direct L-shell x-ray fluorescence imaging of gold nanoparticles using a benchtop x-ray source Med. Phys. 40 080702
17. McGuire W P, Hoskins W J, Brady M F, Kucera P R, Partridge E E, Look K Y, ClarkePearson D L and Davidson M 1996 Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N. Engl. J. Med. 334 1-6 (Pubitemid 26012496)
18. Nuyts J, De Man B, Dupont P, Defrise M, Suetens P and Mortelmans L 1998 Iterative reconstruction for helical CT: a simulation study Phys. Med. Biol. 43 729-37 (Pubitemid 28168404)
19. Perez C A, Radtke M, Sanchez H J, Tolentino H, Neuenshwander R T, Barg W, Rubio M, Bueno M I S, Raimundo I M and Rohwedder J J R 1999 Synchrotron radiation x-ray fluorescence at the LNLS: beamline instrumentation and experiments X-Ray Spectrom. 28 320-6
20. Ricketts K, Castoldi A, Guazzoni C, Ozkan C, Christodoulou C, Gibson A P and Royle G J 2012 A quantitative x-ray detection system for gold nanoparticle tumour biomarkers Phys. Med. Biol. 57 5543-55
21. Rogers D W O, Walters B and Kawrakow I 2006 BEAMnrc users manual (Ottawa: NRCC) NRCC Report PIRS-0509
22. Rose A 1973 Vision: Human and Electronic (New York: Plenum)
23. Rust G F and Weigelt J 1998 X-ray fluorescent computer tomography with synchrotron radiation IEEE Trans. Nucl. Sci. 45 75-88 (Pubitemid 128744655)
24. Takeda T, Wu J, Thet Thet L, Huo Q, Yuasa T, Hyodo K, Dilmanian F A and Akatsuka T 2009 X-ray fluorescent CT imaging of cerebral uptake of stable-iodine perfusion agent iodoamphetamine analog IMP in mice J. Synchrotron Radiat. 16 57-62
25. Thompson A C and Vaughan D 2001 X-Ray Data Booklet (Berkeley, CA: Lawrence Berkeley National Laboratory)
26. Walters B R B, Kawrakow I and Rogers D W O 2007 DOSXYZnrc users manual (Ottawa: NRCC) NRCC Report PIRS-794
27. Yu Q W, Takeda T, Yuasa T, Hasegawa Y, Wu J, Thet Thet L, Hyodo K, Dilmanian F A, Itai Y and Akatsuka T 2001 Preliminary experiment of fluorescent x-ray computed tomography to detect dual agents for biological study J. Synchrotron Radiat. 8 1030-4 (Pubitemid 33579944)